000			01554cam a22003137a 4500
001			12277723
003			SE-LIBR
005			20120809144730.0
007			cr cn||a||||||
008			110802s2011 dcua ob 000 0 eng c
040			_aDID _dOCLCQ _dSipr
041			_aeng
100	1		_aFinlay, Brian D.
245	1	0	_aCounterfeit drugs and national security _h[electronic resource] / _cBrian D. Finlay
260			_aWashington, DC : _bStimson Center, _c2011
300			_a1 PDF-file (13 p.)
500			_aFebruary 2011.
500			_aTitle from cover screen (viewed Mar. 8, 2011).
504			_aIncludes bibliographical references (p. 13).
520			_aThe deadly implications of counterfeit drugs are well understood to be a central challenge to the integrity of public health systems around the globe, as well as a direct threat to our individual health and welfare. What is less understood is that the profits from this sinister crime are increasingly being co-opted by an array of organized criminal groups and terrorist entities as a means by which to fund their nefarious operations around the world. As such, counterfeit pharmaceuticals pose a direct threat to national and international security.
538			_aMode of access: World Wide Web.
538			_aSystem requirements: Adobe Reader.
650		7	_adrugs _xterrorism
650		7	_adrugs _xcriminality
710	2		_aHenry L. Stimson Center
852			_hCD127 G11_916
856	4	0	_uhttp://www.stimson.org/books-reports/counterfeit-drugs-and-national-security/
942			_cREP
999			_c76415 _d76415